Salute e Benessere

PHAXIAM Announces 2023 Full-Year Results and Provides Business Update

Conference callandwebcast(English) on Thursday, March 21, 2024 at 9:30am ET / 2:30pm CETOngoing clinical efforts boding well to create a global phage-therapy leader in high-value indications First clinical results of the Phase 1 study in Endocarditis Infections expected in the second half of 2024Plan to launch the 1 stglobal Phase 2 Proof-Of-Concept study in Prosthetic Joint Infections (PJI) in early 2025, leveraging on PhagoDAIR study Compassionate access program...

Zealand Pharma's Annual General Meeting 2024

Company announcement – No. 17 / 2024 Zealand Pharma's Annual General Meeting 2024Copenhagen, March 20, 2024 -Today, Zealand Pharma A/S ("Zealand") (NASDAQ: ZEAL) (CVR no. 20 04 50 78), held its Annual General Meeting of 2024 as a partly electronic and partly physical general meeting (hybrid meeting).At the meeting, all proposals presented to the General Meeting were adopted.The General Meeting acknowledged the management's report on Zealand's activities in the past financial year...

SEQUANA MEDICAL LAUNCHES EQUITY PLACEMENT AND PROVIDES TRADING UPDATE

THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAW PRESS RELEASE REGULATED INFORMATION – INSIDE INFORMATION 20 March 2024, 04:20 pm CET Ghent, Belgium,20 March 2024 –Sequana Medical NV (Euronext Brussels: SEQUA)(the " Company " or " Sequana Medical "), a pioneer in the treatment of fluid overload in liver...

Orion Corporation: Organising meeting of the Board of Directors

ORION CORPORATIONSTOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 20 MARCH 2024 at 17.00 EET Orion Corporation: Organising meeting of the Board of Directors In its organising meeting, the Board of Directors of Orion Corporation, which was elected today by the Annual General Meeting of the Shareholders, has elected Hilpi Rautelin as Vice Chairman.The compositions of the Board committees were decided to be as follows:Personnel and...

Decisions taken by Orion Corporation's Annual General Meeting on 20 March 2024

ORION CORPORATIONSTOCK EXCHANGE RELEASE – DECISIONS OF GENERAL MEETING 20 MARCH 2024 at 16.50 EET Decisions taken by Orion Corporation's Annual General Meeting on 20 March 2024 At the Annual General Meeting of Orion Corporation held today, the following decisions were made:A dividend of EUR 1.62 per share was confirmed to be paid. The dividend is paid in two instalments. The proposals concerning the election and remuneration of the Board of Directors, the election and...

Needle Coke Market Projected to Reach $7.81 billion by 2030 - Exclusive Report…

The global needle coke market is witnessing significant growth, owing to its crucial role in manufacturing graphite electrodes for electric arc furnaces (EAF) used in steelmaking and its essential contribution to the lithium-ion batteries powering the electric vehicle (EV) industry. This specialized carbon material, known for its unique needle-like crystalline structure, is necessary for advancements in recycling steel scrap, meeting sustainability goals, and powering the next generation of EVs…

Medical Device Contract Manufacturing Market Worth $149.4 billion |…

Browse in-depth TOC on "Medical Device Contract Manufacturing Market" Browse in-depth TOC on "Medical Device Contract Manufacturing Market" 490 - Tables 75 - Figures 500 - Pages Medical Device Contract Manufacturing Market Scope: "Based on medical device contract manufacturing devices by IVD device type, the IVD consumables segment is expected to grow at the highest CAGR during the forecast period." Under IVD device type, IVD consumables is forecasted to grow at...

Revolutionary Evotip Workflow Enables Unprecedented Proteomic Analysis

This revolutionary approach simplifies and enhances the proteomic analysis of minimal cell quantities and liquid biopsies, setting a new standard in sensitivity, throughput, and robustness. By streamlining sample preparation for mass spectrometry, the Evotip workflow enables the seamless, cost-effective identification of proteins from biological matrices like blood plasma. This advancement paves the way for unprecedented insights into diseases at a molecular level, facilitating the discovery of…

Enhancing National Preparedness: Rafa Laboratories Partners with BARDA to…

Rafa Laboratories already manufactures adult atropine autoinjectors, FDA-approved in July 2018, and pediatric atropine autoinjectors authorized for use under FDA Emergency Use Authorization (EUA) in January 2018. Rafa Laboratories already manufactures adult atropine autoinjectors, FDA-approved inJuly 2018, and pediatric atropine autoinjectors authorized for use under FDA Emergency Use Authorization (EUA) inJanuary 2018. Rafa's atropine autoinjectors are widely utilized in military...

OKYO Pharma to Release New and Comprehensive Data from Phase 2 Dry Eye Disease…

LONDON and NEW YORK, March20, 2024(GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment diseases including neuropathic corneal pain (NCP), an ocular condition associated with pain but without an FDA approved therapy, announces that it will be releasing new and comprehensive efficacy data...

IM Cannabis to Report Fourth Quarter and Full Year 2023 Financial Results on…

If you are unable to join us live, a recording of the call will be available on our website at https://investors.imcannabis.com within 24 hours after the call. If you are unable to join us live, a recording of the call will be available on our website athttps://investors.imcannabis.comwithin 24 hours after the call. About IM Cannabis Corp. IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients inIsraeland...

BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and…

Advanced oncology pipeline in mid- and late-stage with plans to have ten or more potentially registrational oncology trials running by the end of 2024 Aiming for first oncology launch in 2026 and ten indication approvals by 2030 as part of BioNTech's strategy to develop combinatorial and synergistic therapeutic approachesEntered strategic collaborations with Biotheus, DualityBio, Medilink and OncoC4 to complement clinical oncology pipeline with innovative antibody-drug...

ProVerum Announces Completion of Enrollment for the ProVIDE Clinical Study for…

ProVerum Announces First Enrollment in the ProVIDE II: Bridging Study ProVerum Announces First Enrollment in the ProVIDE II: Bridging Study The company also announced the commencement of the ProVIDE II: Bridging Study to evaluate the performance of its new low profile flexible, steerable delivery system for deploying the ProVee expander. This second-generation delivery system is the same diameter as a diagnostic cystoscope and ideally suited to an office or out-patient setting...

BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as…

Mainz, Germany, March 20, 2024 (GLOBE NEWSWIRE)– BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that the Supervisory Board has appointed Annemarie Hanekamp to the Management Board as Chief Commercial Officer effective July 1, 2024. She will join BioNTech from Novartis AG (“Novartis”) and succeed Sean Marett in this role.Annemarie Hanekamp is a seasoned pharmaceutical executive experienced in developing patient-focused commercial strategies for innovative...

FDI World Dental Federation releases powerful video message unifying voices in…

"We say that a happy mouth is essential for a happy body because the two are intricately connected and mutually influence each other. Understanding this connection is vital to improve the quality of life for countless people around the world," explains FDI President Dr Greg Chadwick. "We say that a happy mouth is essential for a happy body because the two are intricately connected and mutually influence each other. Understanding this connection is vital to improve the quality of…

Cure51 raises a €15 million seed round to harness the natural power of cancer…

Cure51 was founded in March 2022 by Nicolas Wolikow and Simon Istolainen, alongside seasoned entrepreneurs and four world-renowned oncology centers: Gustave Roussy Institute (IGR, Paris - France), Leon Bérard Center (CLB, Lyon - France), Charité Universitätsmedizin (Berlin - Germany), and Vall d'Hebron (VHIO, Barcelona - Spain). The aim is to pioneer the creation of the world's first global clinical and molecular database of cancer survivors, by rewriting the narrative of cancer. Rather than…

Leading executive search firm Redgrave welcomes Malcolm Devine as new consumer…

David Angel, Managing Partner at Redgrave, expressed his delight about Malcolm's appointment: "Malcolm's deep understanding of the consumer landscape, experience with private equity and family-owned businesses, and passion for people and results make him a perfect addition to our team. We are confident that his extensive knowledge of the sector and his global perspective will help drive continued success for our highly-respected consumer practice." David Angel, Managing Partner at…

Pioneering the Next Frontier: ArisGlobal Unveils Cutting-Edge Safety &…

Advanced Intake ArisGlobal introduced Advanced Intake, powered by LifeSphere NavaX and leveraging Generative AI to revolutionize adverse event intake and overcome recognized pain points. With this offering, ArisGlobal has become the first life sciences R&D technology company to announce innovative offerings with Generative AI. Unprecedented seamless integration capabilities, meanwhile, make it possible to aggregate disparate data sources into a unified platform, fostering a holistic…

UGREEN Unveils Nexode RG 65W Charger in Europe

The Nexode RG stands out as an eccentric tabletop piece and a delightful daily companion. In contrast to the standard designs of ordinary chargers, the Nexode RG boasts a whimsical and distinctive robot design, captivating users who desire more than mere functionality from their chargers. The Nexode RG stands out as an eccentric tabletop piece and a delightful daily companion. In contrast to the standard designs of ordinary chargers, the Nexode RG boasts a whimsical and distinctive robot...

Amazon Spring Sale 2024: Save 15% to 40% on Jackery Mini Power Stations, Solar…

If you need a 230-volt socket and a 12-volt connection in addition to USB, but still want a handy device, the Explorer 500 is available with a 40% discount. For just £334 instead of £556.99, it offers 518 Wh of capacity and 500 Watts of continuous power. This ensures it can power all the essentials for a camping or picnic trip, from cool boxes to cameras. Its compact size of 30 x 19.3 x 24.2 cm means it fits seamlessly into even the smallest tents or bike baskets. If you need a 230-volt…

Cure51 raises a €15 million seed round to harness the natural power of cancer…

Cure51 was founded in March 2022 by Nicolas Wolikow and Simon Istolainen, alongside seasoned entrepreneurs and four world-renowned oncology centers: Gustave Roussy Institute (IGR, Paris - France), Leon Bérard Center (CLB, Lyon - France), Charité Universitätsmedizin (Berlin - Germany), and Vall d'Hebron (VHIO, Barcelona - Spain). The aim is to pioneer the creation of the world's first global clinical and molecular database of cancer survivors, by rewriting the narrative of cancer. Rather than…

PayerPro360 by Thelansis - AI-Powered Tool Streamlining Payer Research for…

Case Study: Thelansis launched a Payer perception study in the United States, France, Italy, and Germany for a biotech company focusing on cell therapy development. Case Study:Thelansis launched a Payer perception study in the United States,France,Italy, andGermany for a biotech company focusing on cell therapy development. Methodology: Aligned with the client's objectives and preferences, we begin with the careful selection of premium and relevant payers using...

COSRX Spring Deal Days Sale: Save Much on TikTok's Favorite Skincare Products at…

Advanced Snail 96 Mucin Power Essence Advanced Snail 96 Mucin Power Essence The TikTok viral COSRXAdvanced Snail 96 Mucin Power Essenceis formulated with filtered snail mucin to protect the skin barrier from losing moisture. Skincare influencers and Amazon reviewers rave about the product for revitalizing and hydrating the skin without irritation. One shopper calls it "the VIP ticket to hydration town," since it will "keep your skin plump and moist, the perfect combination for...

Results from Mont Blanc Phase 3 Trial of Nicox's NCX 470 in Glaucoma Published…

Press Release Results from Mont Blanc Phase 3 Trial of Nicox's NCX 470 in Glaucoma Published in the American Journal of OphthalmologyFirst publication of the data from the Mont Blanc Phase 3 trial in a peer-reviewed journalAuthors conclude: "NCX 470 could become an important first-line therapy for IOP reduction in glaucoma."Topline results from second Phase 3 trial of NCX 470, Denali, expected in H2 2025March 20, 2024 – release at 7:30 am CET Sophia Antipolis, France Nicox...

Altri Comunicati